Health & Life Co., Ltd. (TPEX:1781)
10.85
+0.10 (0.93%)
May 8, 2026, 1:06 PM CST
Health & Life Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -61.67 | 24.24 | -33.23 | -17.55 | -62.34 |
Depreciation & Amortization | 14.67 | 23.48 | 24.44 | 24.18 | 17.17 |
Loss (Gain) From Sale of Assets | - | -0.06 | -0.01 | -1.45 | - |
Loss (Gain) From Sale of Investments | 0.32 | 0.02 | - | - | - |
Provision & Write-off of Bad Debts | -0.01 | 0.01 | 1.06 | -0.69 | -0 |
Other Operating Activities | -3.92 | -4.49 | -4.75 | -16.27 | -26.09 |
Change in Accounts Receivable | 46.25 | -35.13 | 35.68 | -37.84 | -14.29 |
Change in Inventory | 11.46 | 79.3 | 29.18 | 0.42 | -41.57 |
Change in Accounts Payable | -10 | -48.14 | 24.54 | -8.83 | -53.83 |
Change in Unearned Revenue | 5.82 | 2.83 | -11.92 | -1.51 | 11.11 |
Change in Other Net Operating Assets | 0.26 | -8.66 | 19.92 | -21.15 | 38.69 |
Operating Cash Flow | 3.18 | 33.39 | 84.91 | -80.7 | -131.15 |
Operating Cash Flow Growth | -90.46% | -60.67% | - | - | - |
Capital Expenditures | -6.92 | -2.74 | -7.97 | -4.74 | -12.38 |
Sale of Property, Plant & Equipment | - | 0.5 | 0.11 | 2.13 | - |
Sale (Purchase) of Intangibles | -1.27 | -0.11 | -0.13 | -7.58 | -1.53 |
Investment in Securities | 50.14 | -89.27 | -1.05 | - | - |
Other Investing Activities | 0.02 | 2.18 | 0.25 | -0.13 | -2.12 |
Investing Cash Flow | 41.96 | -89.44 | -8.78 | -10.32 | -16.02 |
Short-Term Debt Issued | - | 195.01 | 264 | 312.65 | 878.28 |
Long-Term Debt Issued | - | 217.89 | - | - | - |
Total Debt Issued | - | 412.9 | 264 | 312.65 | 878.28 |
Short-Term Debt Repaid | - | -260.01 | -314.6 | -261.08 | -947.08 |
Long-Term Debt Repaid | -21.77 | -23.97 | -24.06 | -25.67 | -22.27 |
Total Debt Repaid | -21.77 | -283.98 | -338.66 | -286.75 | -969.35 |
Net Debt Issued (Repaid) | -21.77 | 128.93 | -74.66 | 25.9 | -91.07 |
Other Financing Activities | -0.14 | -0.24 | -0.01 | 0.01 | -0.03 |
Financing Cash Flow | -21.91 | 128.68 | -74.67 | 25.91 | -91.1 |
Foreign Exchange Rate Adjustments | -2.61 | 3.67 | -7.38 | 21.73 | 5.03 |
Net Cash Flow | 20.63 | 76.3 | -5.92 | -43.37 | -233.24 |
Free Cash Flow | -3.74 | 30.65 | 76.94 | -85.44 | -143.53 |
Free Cash Flow Growth | - | -60.16% | - | - | - |
Free Cash Flow Margin | -0.94% | 4.34% | 12.80% | -10.71% | -17.68% |
Free Cash Flow Per Share | -0.08 | 0.61 | 1.62 | -1.80 | -3.03 |
Cash Interest Paid | 0.45 | 2.02 | 5.27 | 3.14 | 2.87 |
Cash Income Tax Paid | 1.29 | 0.39 | 0.28 | 0.41 | - |
Levered Free Cash Flow | 18.2 | 9.49 | 82.6 | -85.23 | -117.57 |
Unlevered Free Cash Flow | 21.93 | 11.6 | 85.89 | -83.27 | -115.64 |
Change in Working Capital | 53.78 | -9.8 | 97.39 | -68.91 | -59.89 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.